Mandate

Vinge advises Norra Affars on acquisition of Remium

July 06, 2016

Remium is a leading capital markets services provider in the small to medium sized enterprises segment offering e.g. corporate finance, equity research, asset management and corporate services. The acquisition is a strategic supplement to Norra Affärs’ business concept which primarily comprises lending to small to medium sized enterprises. The acquisition is expected to be completed early autumn 2016 after receipt of the relevant approvals from the Swedish Financial Supervisory Authority.

Vinge’s team consisted of among others partners Peter Sundgren (M&A) and Emma Stuart-Beck (financial regulatory) as well as associates Johan Mattsson and Marith Welin-Berger (M&A), Caroline Krassén and Henrik Schön (financial regulatory), Karin Isacson (employment & benefits) and Rebecka Weitzberg (intellectual property law).

Related

Vinge advises Fortinova Fastigheter AB (publ) on its first SEK 200 million green bond issue

Vinge has advised Fortinova Fastigheter AB (publ) (“Fortinova”) on the company’s first issue of senior unsecured green bonds in an aggregate principal amount of SEK 200 million, under a framework of up to SEK 600 million. Nordea, acted as sole bookrunner in connection with the bond issue.
September 18, 2026

Vinge advises Morrow Bank AB (publ) in connection with the bank’s sale of parts of MedMera Bank and the sale of NPL portfolios

Vinge has advised Morrow Bank AB (publ) in connection with the divestment of parts of MedMera Bank’s operations to a leading global credit investment firm. The divestment is structured as a sale of shares and priced at a premium of approximately SEK 90 million above equity value as per the completion date. The transaction includes parts of MedMera’s banking operations such as IT infrastructure, organisation and management, whilst Morrow Bank retains MedMera’s performing loans, deposits, customers, the MedMera brand, the Coop partnership agreement as well as key personnel.
September 15, 2026

Vinge advises HealthCap in conjunction with its investment in AMRA Medical

HealthCap is investing in AMRA Medical AB, a company that analyses whole-body MRI images to classify and quantify an individual’s muscle and fat tissue throughout the body and places this in relation to human health and disease.
September 15, 2026